Replies to post #16098 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Orencia's global sales in 4Q16 had an annualized run rate of $2.5B, +16% YoY:

http://s2.q4cdn.com/139948097/files/doc_financials/q4-2016/Q42016-Earnings-Release.pdf (page 9)

[DewDiligence]

Orencia selling at a $2.5B annualized rate with 10% YoY growth, according to the 3Q17 results reported by BMY today (https://investors.bms.com/iframes/press-releases/press-release-details/2017/Bristol-Myers-Squibb-Reports-Third-Quarter-Financial-Results/default.aspx ).

68% of worldwide Orencia sales are from the US.